Back

Exercise dose and threshold for adverse outcome in arrhythmogenic cardiomyopathy

26 August 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Cardiomyopathies: new insights Cardiomyopathies ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Oyvind H Lie

Oslo University Hospital Rikshospitalet, Oslo (Norway)

8 More presentations in this session

Presentation thumbnail
Immune-mediated myocardial inflammation in Fabry Disease cardiomyopathy
Doctor A. Frustaci (Rome, IT)
Abstract
Presentation thumbnail
Takotsubo cardiomyopathy complicated by cardiogenic shock. Insights from the nationwide RETAKO Registry
Doctor M. Almendro (Seville, ES)
Abstract Slides Video
Presentation thumbnail
Discordance between the criteria for ICD implantation in the primary prevention of sudden death among patients with hypertrophic cardiomyopathy
Doctor P. Freitas (Carnaxide, PT)
Abstract Slides Video
Presentation thumbnail
Cardiac transplantation in hypertrophic cardiomyopathy in the united states: 2003-2011.
Doctor J. Shirani (Bethlehem, US)
Abstract Slides Video
Presentation thumbnail
Cardiac sarcoidosis may meet the diagnostic criteria for arrhythmogenic right ventricular cardiomyopathy
Doctor P. Simonen (Helsinki, FI)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiomyopathies: new insights

The Event

Event poster

ESC Congress 2017

26 August - 30 August 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources